<DOC>
	<DOC>NCT00171483</DOC>
	<brief_summary>Study to assess the effects of tegaserod added to PPI therapy in the resolution of heartburn and regurgitation in patients with incomplete relief from PPIs .</brief_summary>
	<brief_title>Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Tegaserod</mesh_term>
	<criteria>Heartburn for at least 3 days in the week prior to screening Regurgitation for at least 3 days in the week prior to screening Stable dose PPI therapy &gt; 4 weeks Incomplete relief on daily PPI therapy &gt; 4 weeks Evidence of structural abnormality of the gastrointestinal tract or disease/conditions Previous gastrointestinal surgery that may influence esophageal motor function Evidence of cathartic colon or a history of laxative use Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>GERD</keyword>
	<keyword>PPI</keyword>
	<keyword>heartburn</keyword>
	<keyword>regurgitation</keyword>
</DOC>